85866-02-0

Basic information

• Product Name: 7-OCTENE-1,2-DIOL
• Synonyms: 7-OCTENE-1,2-DIOL;oct-7-ene-1,2-diol;7-OCTENE-1,2-DIOL, 97% (NO BULK SALES ALLOWED);7-Octene-1,2-diol, GC 97%;Einecs 288-704-6;)-1-Octene-7,8-diol;7,8-Dihydroxy-1-octene;7-Octene-1,2-diol 97%
• CAS NO: 85866-02-0
• Molecular Formula: C₈H₁₆O₂
• Molecular Weight: 144.21
• EINECS: 288-704-6
• Product Categories: Alcohols;Monomers;Polymer Science
• Mol File: 85866-02-0.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 256°Cat760mmHg
• Flash Point: 113 °C
• Appearance: /
• Density: 0.941 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00238mmHg at 25°C
• Refractive Index: n20/D 1.4625(lit.)
• PKA: 14.44±0.20(Predicted)
• CAS DataBase Reference: 7-OCTENE-1,2-DIOL(CAS DataBase Reference)
• NIST Chemistry Reference: 7-OCTENE-1,2-DIOL(85866-02-0)
• EPA Substance Registry System: 7-OCTENE-1,2-DIOL(85866-02-0)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 85866-02-0(Hazardous Substances Data)

Usage

General Description

7-Octene-1,2-diol, also known as 1,2-Octanediol, is a chemical compound with the molecular formula C8H18O2. It is classified as a diol, containing two hydroxyl functional groups. 7-OCTENE-1,2-DIOL is primarily used as a precursor to various other chemicals, including pharmaceuticals, solvents, and fragrances. It is commonly employed in the production of plasticizers, lubricants, and surfactants. Additionally, 7-Octene-1,2-diol has antimicrobial properties, making it useful in the formulation of personal care products and cosmetics. Overall, 7-Octene-1,2-diol is a versatile chemical with a range of industrial and commercial applications.

InChI:InChI=1/C8H16O2/c1-2-3-4-5-6-8(10)7-9/h2,8-10H,1,3-7H2

Upstream product

• 3710-30-3 1,7-Octadiene 
• 52485-73-1 1,2-epoxy-7-octene 

Downstream Products

• 1274891-85-8 2-(5'-hexenyl)glycine 
• 1181215-37-1 C₃₀H₄₂BrN₃O₆ 
• 1039171-10-2 C₁₈H₃₁NO₅ 
• 26524-71-0 5-(hex-5-en-1-yl)dihydrofuran-2(3H)-one 
• 67114-38-9 5-(hex-3-en-1-yl)dihydrofuran-2(3H)-one 
• 1310810-11-7 (E)-8-phenyloct-7-ene-1,2-diol 
• 1310810-12-8 (E)-8-(o-tolyl)oct-7-ene-1,2-diol 
• 368423-70-5 Benzoic acid (3S,4S)-2-but-3-enyl-3-isopropyl-5-oxo-4-(2-oxo-oct-7-enyl)-cyclopent-1-enyl ester 
• 368423-72-7 Benzoic acid (1S,15S)-15-isopropyl-3,14-dioxo-bicyclo[10.2.1]pentadec-12-en-13-yl ester 
• 368423-71-6 Benzoic acid (Z)-(1S,15S)-15-isopropyl-3,14-dioxo-bicyclo[10.2.1]pentadeca-8,12-dien-13-yl ester 
• 556776-91-1 2,2-dimethyl-propionic acid 3-[(benzyl-dimethyl-silanyl)-methylene]-9-(2,2-dimethyl-[1,3]dioxolan-4-yl)-non-5-enyl ester 
• 300831-21-4 (S)-2-(tert-butoxycarbonylamino)non-8-enoic acid 
• 756894-33-4 ethyl (Z)-2-acetamido-2,8-nonadienoate 
• 300831-20-3 ethyl (S)-2-acetamido-8-nonenoate 

Relevant articles and documents

DERMATOLOGICAL COMPOSITIONS AND METHODS

Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; by administration of various compounds, including alcohols, diols and/or triols and their analogues.

Treatment of diseases mediated by the nitric oxide/cGMP/protein kinase G pathway

Disclosed are methods and compositions for stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway, by administration of various compounds including alcohols, diols and/or triols and their analogues.